Casey Orvin

Chief Commercial Officer

Alcanza Clinical Research

With nearly 25 years of experience in the research site space, Casey has a long and exemplary career history in pharmaceutical research site services including serving as past President of the Society for Clinical Research Sites (SCRS), a global organization representing nearly 10,000 clinical research sites in 47 countries within the pharmaceutical industry.

Casey began his career leading a large pharmaceutical research site network, Research Solutions. In 2007, he was recruited to join Clinical Research Advantage/Radiant as EVP of BD and successfully led a network of over 75 research sites conducting clinical trials for pharmaceuticals, vaccines, and medical devices. In 2015, Casey and the executive team at Radiant merged with Synexus, a division of PPD. With Casey’s guidance, Synexus (now AES) continued to expand to 215 global clinical sites in 4 continents and over 15 countries. Casey also served as SVP of Pharmaceutical Relationships at StudyKik, and recently was the CCO for CenExel. Casey now serves as the CCO of Alcanza – a large owned and integrated network of research sites conducting inpatient and outpatient studies with a dedication to reducing barriers to clinical research with sites located in underrepresented patient populations across the US and Puerto Rico.

Casey is passionate about representing the site voice within the industry while ensuring every research patient’s journey is a positive one. As a thought leader in the industry, Casey is regularly invited to be a keynote speaker and panelist and is often quoted by the leading publications covering the clinical research landscape. In 2020, he was recognized in PharmaVoice as one of the 100 Most Inspiring People in the industry.

Speaker Sessions